ASH1L expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.89250000004471E-07 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.70613000000097E-05 |
Normal-vs-Stage2 |
1.928150E-02 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
2.299600E-02 |
Stage1-vs-Stage2 |
2.636800E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
2.952800E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
9.089800E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.61829999995233E-06 |
Normal-vs-AfricanAmerican |
4.138100E-02 |
Normal-vs-Asian |
3.402300E-02 |
Caucasian-vs-AfricanAmerican |
4.472800E-01 |
Caucasian-vs-Asian |
6.191400E-01 |
AfricanAmerican-vs-Asian |
1.847840E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.462400E-03 |
Normal-vs-Female |
3.63189999996738E-06 |
Male-vs-Female |
6.977400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
8.411700E-02 |
Normal-vs-Extreme_Weight |
1.208310E-04 |
Normal-vs-Obese |
4.515900E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
9.949800E-01 |
Normal_Weight-vs-Obese |
7.914000E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
6.301000E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.772580E-01 |
Normal-vs-Age(41-60Yrs) |
9.832000E-04 |
Normal-vs-Age(61-80Yrs) |
5.198400E-04 |
Normal-vs-Age(81-100Yrs) |
2.866000E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.614170E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.988600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.789200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.575600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.077800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.729400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
6.037200E-01 |
Normal-vs-Grade 3 |
5.495400E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
7.402000E-01 |
Grade 2-vs-Grade 4 |
6.037200E-01 |
Grade 3-vs-Grade 4 |
5.495400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.94709999999221E-05 |
Normal-vs-N1 |
2.415900E-02 |
N0-vs-N1 |
1.297390E-01 |
|
|